Home Newsfeeds Maxim Group Downgrades 9 Meters Biopharma to Hold

Maxim Group Downgrades 9 Meters Biopharma to Hold

Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.

Rushmore Reaches Definitive Agreement To Sell Residential Mortgage Servicing Platform To Mr. Cooper Group; Transaction Includes ~250,000 Customers And $37B In Unpaid Principal Balance

By Happy Mohamed

April 26, 12:02 PM

Transaction Includes Approximately 250,000 Customers and $37 Billion in Unpaid Principal Balance DALLAS, April 26, 2023 /PRNewswire/ -- Rushmore Loan Management Services LLC

COOP

Netflix Could Face Legal Action Over South Korean Crime Drama In Suriname: What You Should Know

By Bhavik Nair

September 15, 4:05 AM

Suriname is considering legal action against the producers of South Korea's hit Netflix Inc (NASDAQ: NFLX) series "Narco-Saints" which it believes fosters negative images of the nation by portraying it as a "narco-state." The story was

NFLX

Analyst Ratings

Goldman Sachs Maintains Buy Rating for Bank of N.T Butterfield: Here’s What You Need To Know

By Benzinga Insights

July 14, 12:05 PM

Goldman Sachs has decided to maintain its Buy rating of Bank of N.T Butterfield (NYSE:NTB) and raise its price target from $42.00 to $47.00. Shares of Bank of N.T Butterfield are trading down 1.2% over the last 24 hours, at $31.41 per share.

NTB